Metastatic pheochromocytoma occurred in 4 of 191 patients with VHL (2%), as opposed to 1 of 330 patients with MEN 2 (0.3%) (difference, 2%; 95% CI, 0%-5%; P = .06). The gene discussed is VHL; the disease is pheochromocytoma.